The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood

Seiichi Kato, Toshiaki Shimizu, Shigeru Toyoda, Benjamin D Gold, Shinobu Ida, Takashi Ishige, Shigeru Fujimura, Shigeru Kamiya, Mutsuko Konno, Kentaro Kuwabara, Kosuke Ushijima, Norikazu Yoshimura, Yoshiko Nakayama, Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition, Seiichi Kato, Toshiaki Shimizu, Shigeru Toyoda, Benjamin D Gold, Shinobu Ida, Takashi Ishige, Shigeru Fujimura, Shigeru Kamiya, Mutsuko Konno, Kentaro Kuwabara, Kosuke Ushijima, Norikazu Yoshimura, Yoshiko Nakayama, Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition

Abstract

The Japan Pediatric Helicobacter pylori Study Group published the first guidelines on childhood H. pylori infection in 1997. They were later revised by the Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition (JSPGHAN). The H. pylori eradication rates, when employing triple therapy with amoxicillin and clarithromycin, currently recommended as the first-line therapy of H. pylori infection in Japan, have substantially decreased, creating an important clinical problem worldwide. In Japanese adults, the "test-and-treat" strategy for H. pylori infection is under consideration as an approach for gastric cancer prevention. However, the combined North American and European pediatric guidelines have rejected such a strategy for asymptomatic children. As risk for gastric cancer development is high in Japan, determining whether the "test-and-treat" strategy can be recommended in children has become an urgent matter. Accordingly, the JSPGHAN has produced a second revision of the H. pylori guidelines, which includes discussion about the issues mentioned above. They consist of 19 clinical questions and 34 statements. An H. pylori culture from gastric biopsies is recommended, not only as a diagnostic test for active infection but for antimicrobial susceptibility testing to optimize eradication therapy. Based upon antimicrobial susceptibility testing of H. pylori strains (especially involving clarithromycin), an eradication regimen including use of the antibiotics to which H. pylori is susceptible is recommended as the first-line therapy against H. pylori-associated diseases. The guidelines recommend against a "test-and-treat" strategy for H. pylori infection for asymptomatic children to protect against the development of gastric cancer because there has been no evidence supporting this strategy.

Keywords: Helicobacter pylori; antibiotic resistance; child; eradication therapy; gastric cancer.

Conflict of interest statement

S.F. has received speaker’s fees from Taisho Toyama Pharmaceutical Co., Ltd.

© 2020 The Authors. Pediatrics International published by John Wiley & Sons Australia, Ltd on behalf of Japan Pediatric Society.

References

    1. Kato S, Kobayashi A, Sugiyama T et al Guideline of eradication therapy for childhood Helicobacter pylori infection. Jpn. J. Pediatr. Gastroenterol. Nutr. 1997; 11: 173–6. [in Japanese].
    1. Kato S, Konno M, Shimizu T et al Guideline on diagnosis and management of childhood Helicobacter pylori infection. J. Jpn. Pediatr. Soc. 2005; 109: 1297–300. [in Japanese].
    1. Jones NL, Koletzko S, Goodman K et al Joint ESPGHAN/NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents (update 2016). J. Pediatr. Gastroenterol. Nutr. 2017; 64: 991–1003.
    1. Kato S, Shimizu T, Toyoda S et al The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood (the Japanese edition). Jpn. J. Pediatr. Gastroenterol. Hepatol. Nutr. 2018; 32: 92–136. [in Japanese].
    1. Kojimahara N, Nakayama T, Morizane T, Yamaguchi N, Yoshida M, (eds). Minds Manual for Guideline Development 2017. Japan Council for Quality Health Care, Tokyo, 2017. [in Japanese].
    1. Kato S, Abukawa D, Furuyama N et al Helicobacter pylori reinfection rates in children after eradication therapy. J. Pediatr. Gastroenterol. Nutr. 1998; 27: 543–6.
    1. Rowland M, Kumar D, Daly L, O'Connor P, Vaughan D, Drumm B. Low rates of Helicobacter pylori reinfection in children. Gastroenterology 1999; 117: 336–41.
    1. Czinn SJ. Helicobacter pylori infection: detection, investigation, and management. J. Pediatr. 2005; 146: S21–6.
    1. Konno M, Fujii N, Yokota S et al Five‐year follow‐up study of mother‐to‐child transmission of Helicobacter pylori infection detected by a random amplified polymorphic DNA fingerprinting method. J. Clin. Microbiol. 2005; 43: 2246–50.
    1. Magistà AM, Ierardi E, Castellaneta S et al Helicobacter pylori status and symptom assessment two years after eradication in pediatric patients from a high prevalence area. J. Pediatr. Gastroenterol. Nutr. 2005; 40: 312–8.
    1. Feydt‐Schmidt A, Kindermann A, Konstantopoulos N et al Reinfection rate in children after successful Helicobacter pylori eradication. Eur. J. Gastroenterol. Hepatol. 2002; 14: 1119–23.
    1. Halitim F, Vincent P, Michaud L et al High rate of Helicobacter pylori reinfection in children and adolescents. Helicobacter 2006; 11: 168–72.
    1. Ford AC, Delaney BC, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev 2006; 4: CD003840.
    1. Leodolter A, Kulig M, Brasch H, Meyer‐Sabellek W, Willich SN, Malfertheiner P. A meta‐analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori‐associated gastric or duodenal ulcer. Aliment. Pharmacol. Ther. 2001; 15: 1949–58.
    1. Shcherbakov PL, Filin VA, Volkov IA, Tatarinov PA, Belousov YB. A randomized comparison of triple therapy Helicobacter pylori eradication regimens in children with peptic ulcers. J. Int. Med. Res. 2001; 29: 147–53.
    1. Huang FC, Chang MH, Hsu HY, Lee PI, Shun CT. Long‐term follow‐up of duodenal ulcer in children before and after eradication of Helicobacter pylori . J. Pediatr. Gastroenterol. Nutr. 1999; 28: 76–80.
    1. Kato S, Nishino Y, Ozawa K et al The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease. J. Gastroenterol. 2004; 39: 734–8.
    1. Hashimoto T, Hachiya M, Tsukimoto I et al Retrospective study of 33 cases of gastric and duodenal ulcers. J. Jpn. Pediatr. Soc. 2002; 106: 882–6. [in Japanese].
    1. Huang SC, Sheu BS, Lee SC, Yang HB, Yang YJ. Etiology and treatment of childhood peptic ulcer disease in Taiwan: a single center 9‐year experience. J. Formos. Med. Assoc. 2010; 109: 75–81.
    1. Fukuda Y, Shinozaki K, Sasaki T et al Acute gastric mucosal lesions caused by acute Helicobacter pylori infection ‐ clinical outcomes of six cases and problems in the diagnosis of H. pylori infection. Nihon Shokakibyo Gakkai Zasshi 2014; 111: 899–908. [in Japanese].
    1. Okabe N, Masaoka N, Ogawa M et al A study on the detection of Helicobacter pylori in children with gastric and duodenal diseases. Kansenshogaku Zasshi 1993; 67: 781–4. [in Japanese].
    1. Macarthur C. Helicobacter pylori infection and childhood recurrent abdominal pain: lack of evidence for a cause and effect relationship. Can. J. Gastroenterol. 1999; 13: 607–10.
    1. Bode G, Rothenbacher D, Brenner H, Adler G. Helicobacter pylori and abdominal symptoms: a population‐based study among preschool children in southern Germany. Pediatrics 1998; 101: 634–7.
    1. Dore MP, Fanciulli G, Tomasi PA et al Gastrointestinal symptoms and Helicobacter pylori infection in school‐age children residing in Porto Torres, Sardinia, Italy. Helicobacter 2012; 17: 369–73.
    1. Tindberg Y, Nyrén O, Blennow M, Granström M. Helicobacter pylori infection and abdominal symptoms among Swedish school children. J. Pediatr. Gastroenterol. Nutr. 2005; 41: 33–8.
    1. Ozen H, Dinler G, Akyön Y, Koçak N, Yüce A, Gürakan F. Helicobacter pylori infection and recurrent abdominal pain in Turkish children. Helicobacter 2001; 6: 234–8.
    1. Wewer V, Andersen LP, Paerregaard A et al Treatment of Helicobacter pylori in children with recurrent abdominal pain. Helicobacter 2001; 6: 244–8.
    1. Levine A, Milo T, Broide E et al Influence of Helicobacter pylori eradication on gastroesophageal reflux symptoms and epigastric pain in children and adolescents. Pediatrics 2004; 113: 54–8.
    1. Ashorn M, Rägö T, Kokkonen J, Ruuska T, Rautelin H, Karikoski R. Symptomatic response to Helicobacter pylori eradication in children with recurrent abdominal pain: double blind randomized placebo‐controlled trial. J. Clin. Gastroenterol. 2004; 38: 646–50.
    1. Malfertheiner P, Megraud F, O'Morain C et al Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772–81.
    1. Asaka M, Kato M, Takahashi S et al Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 2010; 15: 1–20.
    1. Sugano K, Tack J, Kuipers EJ et al Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015; 64: 1353–67.
    1. Brigic E, Hadzic D, Mladina N. Childhood and Coress model of carcinogenesis. Med. Arch. 2012; 66: 375–7.
    1. Ozawa K, Kato S, Sekine H et al Gastric epithelial cell turnover and mucosal protection in Japanese children with Helicobacter pylori infection. J. Gastroenterol. 2005; 40: 234–46.
    1. Pacifico L, Anania C, Osborn JF et al Long‐term effects of Helicobacter pylori eradication on circulating ghrelin and leptin concentrations and body composition in prepubertal children. Eur. J. Endocrinol. 2008; 158: 323–32.
    1. Buonavolontà R, Miele E, Russo D, Vecchione R, Staiano A. Helicobacter pylori chronic gastritis in children: to eradicate or not to eradicate? J. Pediatr. 2011; 159: 50–6.
    1. Ashorn M, Ruuska T, Karikoski R, Miettinen A, Mäki M. Helicobacter pylori gastritis in dyspeptic children. A long‐term follow‐up after treatment with colloidal bismuth subcitrate and tinidazole. Scand. J. Gastroenterol. 1994; 29: 203–8.
    1. Blecker U, McKeithan TW, Hart J, Kirschner BS. Resolution of Helicobacter pylori‐associated gastric lymphoproliferative disease in a child. Gastroenterology 1995; 109: 973–7.
    1. Ohno Y, Kosaka T, Muraoka I et al Remission of primary low‐grade gastric lymphomas of the mucosa‐associated lymphoid tissue type in immunocompromised pediatric patients. World J. Gastroenterol. 2006; 12: 2625–8.
    1. Al Furaikh SS. Remission of high‐grade B‐cell lymphoma in a pediatric patient following Helicobacter pylori eradication. Pediatr. Int. 2011; 53: 105–7.
    1. Hill ID, Sinclair‐Smith C, Lastovica AJ, Bowie MD, Emms M. Transient protein losing enteropathy associated with acute gastritis and campylobacter pylori . Arch. Dis. Child 1987; 62: 1215–9.
    1. Cohen HA, Shapiro RP, Frydman M, Varsano I. Childhood protein‐losing enteropathy associated with Helicobacter pylori infection. J. Pediatr. Gastroentel. Nutr. 1991; 13: 201–3.
    1. Yamada M, Sumazaki R, Adachi H et al Resolution of protein‐losing hypertrophic gastropathy by eradication of Helicobacter pylori . Eur. J. Pediatr. 1997; 156: 182–5.
    1. Tokuhara D, Okano Y, Asou K, Tamamori A, Yamano T. Cytomegalovirus and Helicobacter pylori co‐infection in a child with Menetrier disease. Eur. J. Pediatr. 2007; 166: 63–5.
    1. Tokuhara D, Hirokawa H, Yamano T, Okano Y. Protein losing gastropathy in a child and Guillan Barre syndrome in a father caused by intrafamilial infection. Pediatr. Int. 2010; 52: e167–70.
    1. Fretzayas A, Moustaki M, Alexopoulou E, Nicolaidou P. Menetrier's disease associated with Helicobacter pylori: three cases with sonographic findings and a literature review. Ann. Trop. Paediatr. 2011; 31: 141–7.
    1. Annibale B, Capurso G, Lahner E et al Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anemia. Gut 2003; 52: 496–501.
    1. Azab SF, Esh AM. Serum hepcidin levels in Helicobacter pylori‐infected children with iron‐deficiency anemia: a case‐control study. Ann. Hematol. 2013; 92: 1477–83.
    1. Kato S, Nakajima S, Nishino Y et al Association between gastric atrophy and Helicobacter pylori infection in Japanese children: a retrospective multicenter study. Dig. Dis. Sci. 2006; 51: 99–104.
    1. Kato S, Ozawa K, Koike T et al Effect of Helicobacter pylori infection on gastric acid secretion and meal‐stimulated serum gastrin in children. Helicobacter 2004; 9: 100–5.
    1. Yokota S, Konno M, Mino E, Sato K, Takahashi M, Fujii N. Enhanced Fe ion‐uptake activity in Helicobacter pylori strains isolated from patients with iron‐deficiency anemia. Clin. Infect. Dis. 2008; 46: e31–3.
    1. Yokota S, Toita N, Yamamoto S, Fujii N, Konno M. Positive relationship between a polymorphism in Helicobacter pylori neutrophil‐activating protein a gene and iron‐deficiency anemia. Helicobacter 2013; 18: 112–6.
    1. Shan W, Kung FH, Ge R. Comparison of iron‐binding ability between Thr70‐NapA and Ser70‐NapA of Helicobacter pylori . Helicobacter 2016; 21: 192–200.
    1. Konno M, Muraoka S, Takahashi M, Imai T. Iron‐deficiency anemia associated with Helicobacter pylori gastritis. J. Pediatr. Gastroenterol. Nutr. 2000; 31: 52–6.
    1. DuBois S, Kearney DJ. Iron‐deficiency anemia and Helicobacter pylori infection. a review of the evidence. Am. J. Gastroenterol. 2005; 100: 453–9.
    1. Qu XH, Huang XL, Xiong P et al Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta‐analysis. World J. Gastroenterol. 2010; 16: 886–96.
    1. Hudak L, Jaraisy A, Haj S, Muhsen K. An updated systematic review and meta‐analysis on the association between Helicobacter pylori infection and iron deficiency anemia. Helicobacter 2017; 22: 1–16.
    1. Malfertheiner P, Megraud F, O'Morain CA et al Management of Helicobacter pylori infection ‐ the Maastricht V/Florence Consensus Report. Gut 2017; 66: 6–30.
    1. Fujimura K, Kuwana M, Kurata Y et al Is eradication therapy useful as the first line of treatment in Helicobacter pylori‐positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int. J. Hematol. 2005; 81: 162–8.
    1. Fujimura K, Miyagawa Y, Kurata Y, Kuwana M, Tomiyama Y, Murata M. Reference guide for management of adult idiopathic thrombocytopenic purpura (ITP) 2012 version. Rinsho Ketsueki 2012; 53: 433–42. [in Japanese].
    1. Kuwana M. Helicobacter pylori‐associated immune thrombocytopenia: clinical features and pathogenic mechanisms. World J. Gastroenterol. 2014; 20: 714–23.
    1. Brito HS, Braga JA, Loggetto SR, Machado RS, Granato CF, Kawakami E. Helicobacter pylori infection & immune thrombocytopenic purpura in children and adolescents: a randomized controlled trial. Platelets 2015; 26: 336–41.
    1. Franchini M, Cruciani M, Mengoli C, Pizzolo G, Veneri D. Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta‐analysis. J. Antimicrob. Chemother. 2007; 60: 237–46.
    1. Franchini M, Vescovi PP, Garofano M, Veneri D. Helicobacter pylori‐associated idiopathic thrombocytopenic purpura: a narrative review. Semin. Thromb. Hemost. 2012; 38: 463–8.
    1. Russo G, Miraglia V, Branciforte F et al Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. Pediatr. Blood Cancer 2011; 56: 273–8.
    1. Ferrara M, Capozzi L, Russo R. Effect of Helicobacter pylori eradication on platelet count in children with chronic idiopathic thrombocytopenic purpura. Hematology 2009; 14: 282–5.
    1. Shirahata A, Ishii E, Eguchi H et al Consensus guidelines for diagnosis and treatment of childhood idiopathic thrombocytopenic purpura. Int. J. Hematol. 2006; 83: 29–38.
    1. Magen E, Mishal J. Possible benefit from treatment of Helicobacter pylori in antihistamine‐resistant chronic urticaria. Clin. Exp. Dermatol. 2013; 38: 7–12.
    1. Fukuda S, Shimoyama T, Umegaki N, Mikami T, Nakano H, Munakata A. Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. J. Gastroenterol. 2004; 39: 827–30.
    1. Yadav MK, Rishi JP, Nijawan S. Chronic urticaria and Helicobacter pylori . Indian J. Med. Sci. 2008; 62: 157–62.
    1. Tebbe B, Geilen CC, Schulzke JD. Helicobacter pylori infection and chronic urticaria. J. Am. Acad. Dermatol. 1996; 34: 685–6.
    1. Sakurane M, Shiotani A, Furukawa F. Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori‐positive Japanese patients. J. Dermatol. 2002; 29: 23–7.
    1. Shiotani A, Okada K, Yanaoka K et al Beneficial effect of Helicobacter pylori eradication in dermatologic diseases. Helicobacter 2001; 6: 60–5.
    1. Tsuchiya S, Sato K, Kamimura T. A case report of chronic urticaria associated with Helicobacter pylori‐infected chronic gastritis. Shonika Rinsho 2012; 65: 2349–54. [in Japanese].
    1. Akelma AZ, Cizmeci MN, Mete E, Tufan N, Bozkurt B. A neglected cause for chronic spontaneous urticaria in children: Helicobacter pylori . Allergol. Immunopathol. (Madr) 2015; 43: 259–63.
    1. Murakami K, Fujioka T, Nishizono A et al Atopic dermatitis successfully treated by eradication of Helicobacter pylori . J. Gastroenterol. 1996; 31: 77–82.
    1. Blaser MJ, Chen Y, Reibman J. Does Helicobacter pylori protect against asthma and allergy? Gut 2008; 57: 561–7.
    1. Lionetti E, Leonardi S, Lanzafame A et al Helicobacter pylori infection and atopic diseases: is there a relationship? A systematic review and meta‐analysis. World J. Gastroenterol. 2014; 20: 17635–47.
    1. Roma E, Miele E. Helicobacter pylori infection in pediatrics. Helicobacter 2015; 20: 47–53.
    1. Fuccio L, Zagari RM, Eusebi LH et al Meta‐analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann. Intern. Med. 2009; 151: 121–8.
    1. Lee YC, Chiang TH, Chou CK et al Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta‐analysis. Gastroenterology 2016; 150: 1113–24.
    1. Fukase K, Kato M, Kikuchi S et al Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open‐label, randomized controlled trial. Lancet 2008; 372: 392–7.
    1. Uemura N, Okamoto S, Yamamoto S et al Helicobacter pylori infection and the development of gastric cancer. N. Eng. J. Med. 2001; 345: 784–9.
    1. Kamada T, Hata J, Sugiu K et al Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9‐year prospective follow‐up study in Japan. Aliment. Pharmacol. Ther. 2005; 21: 1121–6.
    1. Bourke B, Ceponis P, Chiba N et al Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents ‐ an evidence‐based evaluation. Can. J. Gastroenterol. 2005; 19: 399–408.
    1. Dimitrov G, Gottrand F. Does gastric atrophy exist in children? World J. Gastroentrol. 2006; 12: 6274–9.
    1. Kato S, Kikuchi S, Nakajima S. When does gastric atrophy develop in Japanese children? Helicobacter 2008; 13: 278–81.
    1. Ricuarte O, Gutierrez O, Cardona H, Kim JG, Graham DY, El‐Zimaity HM. Atrophic gastritis in young children and adolescents. J. Clin. Pathol. 2005; 58: 1189–93.
    1. Asaka M, Kato M, Graham D. Strategy for eliminating gastric cancer in Japan. Helicobacter 2010; 15: 486–90.
    1. El‐Omar EM, Oien K, Murray LS et al Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori . Gastroenterology 2000; 118: 22–30.
    1. Motta CR, Cunha MP, Queiroz DM et al Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from Northeastern Brazil. Digestion 2008; 78: 3–8.
    1. Vilkin A, Levi Z, Morgenstern S et al Higher gastric mucin secretion and lower gastric acid output in first‐degree relatives of gastric cancer patients. J. Clin. Gastroenterol. 2008; 42: 36–41.
    1. Niv YH. H pylori recurrence after successful eradication. World J. Gastroenterol. 2008; 14: 1477–8.
    1. Yan TL, Hu QD, Zhang Q, Li YM, Liang TB. National rates of Helicobacter pylori recurrence are significantly and inversely correlated with human development index. Aliment. Pharmacol. Ther. 2013; 37: 963–8.
    1. Abu‐Mahfouz MZ, Prasad VM, Santogade P, Cutler AF. Helicobacter pylori recurrence after successful eradication: 5‐year follow‐up in the United States. Am. J. Gastroenterol. 1997; 92: 2025–8.
    1. Take S, Mizuno M, Ishiki K et al Reinfection rate of Helicobacter pylori after eradication treatment: a long‐term prospective study in Japan. J. Gastroenterol. 2012; 47: 641–6.
    1. Okimoto T, Murakami K, Sato R et al Is the recurrence of Helicobacter pylori infection after eradication therapy resultant from recrudescence or reinfection, in Japan. Helicobacter 2003; 8: 186–91.
    1. Adachi M, Mizuno M, Yokota K et al Reinfection rate following effective therapy against Helicobacter pylori infection in Japan. J. Gastroenterol. Hepatol. 2002; 17: 27–31.
    1. Kim MS, Kim N, Kim SE et al Long‐term follow‐up Helicobacter pylori reinfection rate and its associated factors in Korea. Helicobacter 2013; 18: 135–42.
    1. Silva FM, Navarro‐Rodriguez T, Barbuti RC, Mattar R, Hashimoto CL, Eisig JN. Helicobacter pylori reinfection in Brazilian patients with peptic ulcer disease: a 5‐year follow‐up. Helicobacter 2010; 15: 46–52.
    1. Mitchell HM, Hu P, Chi Y, Chen MH, Li YY, Hazell SL. A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China). Gastroenterology 1998; 114: 256–61.
    1. Gisbert JP, Arata IG, Boixeda D et al Role of partner's infection in reinfection after Helicobacter pylori eradication. Eur. J. Gastroenterol. Hepatol. 2002; 14: 865–71.
    1. Knippig C, Arand F, Leodolter A et al Prevalence of H. pylori‐infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two‐year follow‐up. Z. Gastroenterol. 2002; 40: 383–7.
    1. Guarner J, Kalach N, Elitsur Y, Koletzko S. Helicobacter pylori diagnostic tests in children: review of the literature from 1999 to 2009. Eur. J. Pediatr. 2010; 169: 15–25.
    1. Roma‐Giannikou E, Roubani A, Sgouras DN et al Endoscopic tests for the diagnosis of Helicobacter pylori infection in children: Validation of rapid urease test. Helicoabcter 2010; 15: 227–32.
    1. Rutigliano V, Ierardi E, Francavilla R et al Helicobacter pylori and nonulcer dyspepsia in childhood: clinical pattern, diagnostic techniques, and bacterial strains. J. Pediatr. Gastroenterol. Nutr. 1999; 28: 296–300.
    1. Leal YA, Flores LL, Fuentes‐Pananá EM, Cedillo‐Rivera R, Torres J. 13C‐urea breath test for the diagnosis of Helicobacter pylori infection in children: a systematic review and meta‐analysis. Helicobacter 2011; 16: 327–37.
    1. Kato S, Ozawa K, Konno M et al Diagnostic accuracy of the 13C‐urea breath test for childhood Helicobacter pylori infection: a multicenter Japanese study. Am. J. Gastroenterol. 2002; 97: 1668–73.
    1. Leal YA, Cedillo‐Rivera R, Simón JA, Velázquez JR, Flores LL, Torres J. Utility of stool sample‐based tests for the diagnosis of Helicobacter pylori infection in children. J. Pediatr. Gastroenterol. Nutr. 2011; 52: 718–28.
    1. Opekun AR, Gilger MA, Denyes SM et al Helicobacter pylori infection in children of Texas. J. Pediatr. Gastroenterol. Nutr. 2000; 31: 405–10.
    1. Cutler AF, Prasad VM. Long‐term follow‐up of Helicobacter pylori serology after successful eradication. Am. J. Gastroenterol. 1996; 91: 85–8.
    1. Okuda M, Miyashiro E, Koike M et al Serodiagnosis of Helicobacter pylori infection is not accurate for children aged below 10. Pediatr. Int. 2002; 44: 387–90.
    1. Okuda M, Sugiyama T, Fukunaga K, Kondou M, Miyashiro E, Nakazawa T. A strain‐specific antigen in Japanese Helicobacter pylori recognized in sera of Japanese children. Clin. Diagn. Lab. Immunol. 2005; 12: 1280–4.
    1. Ueda J, Okuda M, Nishiyama T, Lin Y, Fukuda Y, Kikuchi S. Diagnostic accuracy of the E‐plate serum antibody test kit in detecting Helicobacter pylori infection among Japanese children. J. Epidemiol. 2014; 24: 47–51.
    1. Okuda M, Nakazawa T, Booka M, Miyashiro E, Yosikawa N. Evaluation of a urine antibody test for Helicobacter pylori in Japanese children. J. Pediatr. 2004; 144: 196–9.
    1. Mabe K, Kikuchi S, Okuda M, Takamasa M, Kato M, Asaka M. Diagnostic accuracy of urine Helicobacter pylori antibody test in junior and senior high school students in Japan. Helicobacter 2017;22 10.1111/hel.12329
    1. Okuda M, Kamiya S, Booka M et al Diagnostic accuracy of urine‐based kits for detection of Helicobacter pylori antibody in children. Pediatr. Int. 2013; 55: 337–41.
    1. Kato S, Tachikawa T, Ozawa K et al Urine‐based enzyme‐linked immunosorbent assay for the detection of Helicobacter pylori infection in children. Pediatrics 2001; 107: e87.
    1. Frenck RW Jr, Fathy HM, Sherif M et al Sensitivity and specificity of various tests for the diagnosis of Helicobacter pylori in Egyptian children. Pediatrics 2006; 118: e1195–202.
    1. Hassall E, Dimmick JE. Unique features of Helicobacter pylori disease in children. Dig. Dis. Sci. 1991; 36: 417–23.
    1. Bahú Mda G, da Silveira TR, Maguilnick I, Ulbrich‐Kulczynski J. Endoscopic nodular gastritis: an endoscopic indicator of high‐grade bacterial colonization and severe gastritis in children with Helicobacter pylori . J. Pediatr. Gastroenterol. Nutr. 2003; 36: 217–22.
    1. Konno M, Takahashi M, Muraoka S et al Endoscopic findings of Helicobacter pylori infection in children. Stomach Intestine 2011; 46: 1353–62. [in Japanese].
    1. Koletzko S, Jones NL, Goodman KJ et al Evidence‐based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J. Pediatr. Gastroenterol. Nutr. 2011; 53: 230–43.
    1. Machado RS, Viriato A, Kawakami E, Patrício FR. The regular arrangement of collecting venules pattern evaluated by standard endoscope and the absence of antrum nodularity are highly indicative of Helicobacter pylori uninfected gastric mucosa. Dig. Liver Dis. 2008; 40: 68–72.
    1. Hidaka N, Nakayama Y, Horiuchi A, Kato S, Sano K. Endoscopic identification of Helicobacter pylori gastritis in children. Dig. Endosc. 2010; 22: 90–4.
    1. Antos D, Crone J, Konstantopoulos N, Koletzko S. Evaluation of a novel rapid one‐step immunochromatographic assay for detection of monoclonal Helicobacter pylori antigen in stool samples from children. J. Clin. Microbiol. 2005; 43: 2598–601.
    1. Yañez P, la Garza AM, Pérez‐Pérez G, Cabrera L, Muñoz O, Torres J. Comparison of invasive and noninvasive methods for the diagnosis and evaluation of eradication of Helicobacter pylori infection in children. Arch. Med. Res. 2000; 31: 415–21.
    1. Tiryaki Z, Yilmaz‐Ciftdoğan D, Kasirga E. Diagnostic value of stool antigen and antibody tests for Helicobacter pylori infection in Turkish children with upper gastrointestinal complaints before and after eradication. Turk. J. Pediatr. 2010; 52: 505–11.
    1. Makristathis A, Barousch W, Pasching E et al Two enzyme immunoassays and PCR for detection of Helicobacter pylori in stool specimens from pediatric patients before and after eradication therapy. J. Clin. Microbiol. 2000; 38: 3710–14.
    1. Oderda G, Rapa A, Marinello D, Ronchi B, Zavallone A. Usefulness of Helicobacter pylori stool antigen test to monitor response to eradication treatment in children. Aliment. Pharmacol. Ther. 2001; 15: 203–6.
    1. Kato S, Nakayama K, Minoura T et al Comparison between the 13C‐urea breath test and stool antigen test for the diagnosis of childhood Helicobacter pylori infection. J. Gastroenterol. 2004; 39: 1045–50.
    1. Kato S, Furuyama N, Ozawa K, Ohnuma K, Iinuma K. Long‐term follow‐up study of serum immunoglobulin G and immunoglobulin A antibodies after Helicobacter pylori eradication. Pediatrics 1999; 104: e22.
    1. Cadranel S, Corvaglia L, Bontems P et al Detection of Helicobacter pylori infection in children with a standardized and simplified 13C‐urea breath test. J. Pediatr. Gastroenterol. Nutr. 1998; 27: 275–80.
    1. Elitsur Y, Tolia V, Gilger MA et al Urea breath test in children: The United States prospective, multicenter study. Helicobacter 2009; 14: 134–40.
    1. Kubota S, Kumagai T, Nakayama Y et al Usefulness of the Helicobacter pylori stool antigen test for diagnosis of Helicobacter pylori infection and assessment of eradication therapy in children. Jpn. J. Med. Techn. 2002; 51: 1265–70. [in Japanese].
    1. Kuloğlu Z, Kansu A, Kirsaçlioğlu CT et al A rapid lateral flow stool antigen immunoassay and (14)C‐urea breath test for the diagnosis and eradication of Helicobacter pylori infection in children. Diagn. Microbiol. Infect. Dis. 2008; 62: 351–6.
    1. Husson MO, Rolland C, Gottrand F et al Evaluation of a Helicobacter pylori stool antigen test for the diagnosis and follow‐up of infections in children. Eur. J. Clin. Microbiol. Infect. Dis. 2000; 19: 787–9.
    1. Gościniak G, Przondo‐Mordarska A, Iwańczak B, Blitek A. Helicobacter pylori antigens in stool specimens of gastritis children before and after treatment. J. Pediatr. Gastroenterol. Nutr. 2003; 36: 376–80.
    1. Roggero P, Bonfiglio A, Luzzani S et al Helicobacter pylori stool antigen test: a method to confirm eradication in children. J. Pediatr. 2002; 140: 775–7.
    1. Kato S, Ozawa K, Okuda M et al Multicenter comparison of rapid lateral flow stool antigen immunoassay and stool antigen enzyme immunoassay for the diagnosis of Helicobacter pylori infection in children. Helicobacter 2004; 9: 669–73.
    1. Kato S, Ozawa K, Okuda M et al Accuracy of the stool antigen test for the diagnosis of childhood Helicobacter pylori infection: a multicenter Japanese study. Am. J. Gastroenterol. 2003; 98: 296–300.
    1. Konstantopoulos N, Rüssmann H, Tasch C et al Evaluation of the Helicobacter pylori stool antigen test (HpSA) for detection of Helicobacter pylori infection in children. Am. J. Gastroenterol. 2001; 96: 677–83.
    1. Prell C, Osterrieder S, Lottspeich C et al Improved performance of a rapid office‐based stool test for detection of Helicobacter pylori in children before and after therapy. J. Clin. Microbiol. 2009; 47: 3980–4.
    1. Schwarzer A, Lottspeich C, Rüssmann H, Panthel K, Koletzko S, Rüssmann H. Evaluation of a novel rapid one‐step monoclonal chromatographic immunoassay for detection of Helicobacter pylori in stool from children. Eur. J. Clin. Microbiol. Infect. Dis. 2007; 26: 475–80.
    1. Hino B, Eliakim R, Levine A et al Comparison of invasive and non‐invasive tests diagnosis and monitoring of Helicobacter pylori infection in children. J. Pediatr. Gastroenterol. Nutr. 2004; 39: 519–23.
    1. Elitsur Y, Yahav J. Helicobacter pylori infection in pediatrics. Helicobacter 2005; 10: 47–53.
    1. Crowley E, Bourke B, Hussey S. How to use Helicobacter pylori testing in paediatric practice. Arch. Dis. Child. Educ. Pract. Ed. 2013; 98: 18–25.
    1. Koletzko S. Noninvasive diagnostic tests for Helicobacter pylori infection in children. Can. J. Gastroenterol. 2005; 19: 433–9.
    1. Nakayama Y, Graham DY. Helicobacter pylori infection: diagnosis and treatment. Expert Rev. Anti Infect. Ther. 2004; 2: 599–610.
    1. Mittal SK, Mathew JL. Helicobacter pylori infection in children: a review. Trop. Gastroenterol. 2003; 24: 106–15.
    1. Vaira D, Vakil N. Blood, urine, stool, breath, money, and Helicobacter pylori . Gut 2001; 48: 287–9.
    1. Oderda G. Management of Helicobacter pylori infection in children. Gut 1998; 43: S10–3.
    1. Gisbert JP, de la Morena F , Abraira V. Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta‐analysis. Am. J. Gastroenterol. 2006; 101: 1921–30.
    1. Okamura T, Suga T, Nagaya T et al Antimicrobial resistance and characteristics of eradication therapy of Helicobacter pylori in Japan: a multi‐generational comparison. Helicobacter 2014; 19: 214–20.
    1. Toracchio S, Cellini L, Di Campli E et al Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. Aliment. Pharmacol. Ther. 2000; 14: 1639–43.
    1. Faber J, Bar‐Meir M, Rudensky B et al Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful? J. Pediatr. Gastroenterol. Nutr. 2005; 40: 571–4.
    1. Arenz T, Antos D, Rüssmann H et al Esomeprazole‐based 1‐week triple therapy directed by susceptibility testing for eradication of Helicobacter pylori infection in children. J. Pediatr. Gastroenterol. Nutr. 2006; 43: 180–4.
    1. Street ME, Caruana P, Caffarelli C et al Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome. Arch. Dis. Child. 2001; 84: 419–22.
    1. Okuda M, Kikuchi S, Mabe K et al Nationwide survey of Helicobacter pylori treatment for children and adolescents in Japan. Pediatr. Int. 2017; 59: 57–61.
    1. Khurana R, Fischbach L, Chiba N et al Meta‐analysis: Helicobacter pylori eradication treatment efficacy in children. Aliment. Pharmacol. Ther. 2007; 25: 523–36.
    1. Kato S, Konno M, Maisawa S et al Results of triple eradication therapy in Japanese children: a retrospective multicenter study. J. Gastroenterol. 2004; 39: 838–43.
    1. Kato S, Fujimura S. Primary antimicrobial resistance of Helicobacter pylori in children during the past 9 years. Pediatr. Int. 2010; 52: 187–90.
    1. Kato S. Evidence‐based Helicobacter pylori eradication therapy in children. Jpn. J. Helicobacter Res. 2016; 17: 60–6. [in Japanese].
    1. Iwańczak BM, Borys‐Iwanicka A, Biernat M, Gościniak G. Assessment of sequential and standard triple therapy in treatment of Helicobacter pylori infection in children dependent on bacteria sensitivity to antibiotics. Adv. Clin. Exp. Med. 2016; 25: 701–8.
    1. Hong J, Yang HR. Efficacy of proton pump inhibitor‐based triple therapy and bismuth‐based quadruple therapy for Helicobacter pylori eradication in Korean children. Pediatr. Gastroenterol. Hepatol. Nutr. 2012; 15: 237–42.
    1. Sirvan BN, Usta MK, Kizilkan NU, Urganci N. Are synbiotics added to the standard therapy to eradicate Helicobacter pylori in children beneficial? A randomized controlled study. Eur. J. Hepato‐Gastroenterol. 2017; 7: 17–22.
    1. Huang J, Zhou L, Geng L et al Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children–a multicentre, open‐labelled study. Aliment. Pharmacol. Ther. 2013; 38: 1230–5.
    1. Konno M. Helicobacter pylori eradication rates in Japanese children‐How to conquer clarithromycin resistance. Jpn. J. Helicobacter Res. 2011; 12: 30–2. [in Japanese].
    1. Kato S, Takeyama J, Ebina K, Naganuma H. Omeprazole‐based dual and triple regimens for Helicobacter pylori eradication in children. Pediatrics 1997; 100: E3.
    1. Gunasekaran TS, Hassall EG. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children. J. Pediatr. 1993; 123: 148–54.
    1. Cucchiara S, Minella R, Lervolino C et al Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis. Arch. Dis. Child. 1993; 69: 655–9.
    1. Kato S, Ebina K, Fujii K, Chiba H, Nakagawa H. Effect of omeprazole in the treatment of refractory acid‐related disease in childhood: endoscopic healing and twenty‐four‐hour intragastric acidity. J. Pediatr. 1996; 128: 415–21.
    1. Gibbons TE, Gold BD. The use of proton pump inhibitors in children: a comprehensive review. Paediatr. Drugs 2003; 5: 25–40.
    1. Boonyaritichaikij S, Kuwabara K, Nagano J, Kobayashi K, Koga Y. Long‐term administration of probiotics to asymptomatic pre‐school children for either the eradication or the prevention of Helicobacter pylori infection. Helicobacter 2009; 14: 202–7.
    1. Fujimura S, Watanabe A, Kimura K, Kaji M. Probiotic mechanism of Lactobacillus gasseri OLL2716 strain against Helicobacter pylori . J. Clin. Microbiol. 2012; 50: 1134–6.
    1. Lu M, Yu S, Deng J et al Efficacy of probiotic supplementation therapy for Helicobacter pylori eradication: a meta‐analysis of randomized controlled trials. PLoS One 2016; 11: e0163743.
    1. Pacifico L, Osborn JF, Bonci E, Romaggioli S, Baldini R, Chiesa C. Probiotics for the treatment of Helicobacter pylori infection in children. World J. Gastroenterol. 2014; 20: 673–83.
    1. Hurduc V, Plesca D, Dragomir D, Sajin M, Vandenplas Y. A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children. Acta Paediatr. 2009; 98: 127–31.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe